Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleDrug Discovery and Translational Medicine
Open Access

Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility

Nobuyuki Takahashi and Yukinori Take
Journal of Pharmacology and Experimental Therapeutics February 2018, 364 (2) 275-286; DOI: https://doi.org/10.1124/jpet.117.244202
Nobuyuki Takahashi
RaQualia Pharma Inc., Nagoya, Aichi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yukinori Take
RaQualia Pharma Inc., Nagoya, Aichi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 364 no. 2 275-286
DOI 
https://doi.org/10.1124/jpet.117.244202
PubMed 
29180359

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received July 30, 2017
  • Accepted November 14, 2017
  • Published online January 18, 2018.

Article Versions

  • Earlier version (November 27, 2017 - 07:57).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2018 The Author(s). This is an open access article distributed under the CC BY Attribution 4.0 International license.

Author Information

  1. Nobuyuki Takahashi1 and
  2. Yukinori Take
  1. RaQualia Pharma Inc., Nagoya, Aichi, Japan
  1. Address correspondence to:
    Yukinori Take, RaQualia Pharma Inc., 8F Daiwa Meieki Building, 1-21-19 Meieki Minami, Nakamura-ku, Nagoya, Aichi 450-0003, Japan. E-mail: yukinori.take{at}raqualia.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2017 to June 2023

AbstractFullPdf
Nov 20175170144
Dec 20172300142
Jan 2018120316197
Feb 201838293109
Mar 201821105103
Apr 2018106584
May 20181011872
Jun 2018108487
Jul 201813165169
Aug 201811133139
Sep 20181483113
Oct 201816142139
Nov 201815190177
Dec 201820124170
Jan 201919147199
Feb 201926181230
Mar 201934289330
Apr 201934269305
May 201912334215
Jun 201915183139
Jul 201921142159
Aug 201915117104
Sep 20198119123
Oct 20199145137
Nov 201924207132
Dec 20199216105
Jan 202014204102
Feb 20201520596
Mar 202021225128
Apr 20201822793
May 202025229107
Jun 20202718984
Jul 20201021385
Aug 2020415369
Sep 20204916261
Oct 20202819953
Nov 20201519373
Dec 20202218479
Jan 2021921065
Feb 20211817285
Mar 20212620697
Apr 20213115575
May 20211118273
Jun 20212518457
Jul 202133248108
Aug 20211021478
Sep 20212621971
Oct 202112255102
Nov 20213126679
Dec 20211224699
Jan 202219253109
Feb 20224020178
Mar 202230294128
Apr 202222296123
May 202226346134
Jun 202240320115
Jul 202229302103
Aug 202232329134
Sep 202231353142
Oct 202255346117
Nov 202245371126
Dec 202231244129
Jan 202323358125
Feb 202315415128
Mar 202357483147
Apr 202318319127
May 202323380119
Jun 202383416

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 364 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 364, Issue 2
1 Feb 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleDrug Discovery and Translational Medicine

Tegoprazan, a Novel Potassium-Competitive Acid Blocker

Nobuyuki Takahashi and Yukinori Take
Journal of Pharmacology and Experimental Therapeutics February 1, 2018, 364 (2) 275-286; DOI: https://doi.org/10.1124/jpet.117.244202

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleDrug Discovery and Translational Medicine

Tegoprazan, a Novel Potassium-Competitive Acid Blocker

Nobuyuki Takahashi and Yukinori Take
Journal of Pharmacology and Experimental Therapeutics February 1, 2018, 364 (2) 275-286; DOI: https://doi.org/10.1124/jpet.117.244202
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PK/PD Relationship of RyR2 Inhibitor ent-Verticilide
  • TAK-994: An Orally Available Orexin 2 Receptor Agonist
  • Siponimod as a novel inhibitor of retinal angiogenesis
Show more Drug Discovery and Translational Medicine

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics